Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7

被引:51
|
作者
Bergstrom, Alexander [1 ]
Katko, Andrew [1 ]
Adkins, Zach [1 ]
Hill, Jessica [1 ]
Cheng, Zishuo [1 ]
Burnett, Mia [1 ]
Yang, Hao [1 ]
Aitha, Mahesh [1 ]
Mehaffey, M. Rachel [2 ]
Brodbelt, Jennifer S. [2 ]
Tehrani, Kamaleddin H. M. E. [3 ]
Martin, Nathaniel I. [3 ]
Bonomo, Robert A. [4 ]
Page, Richard C. [1 ]
Tierney, David L. [1 ]
Fast, Walter [5 ]
Wright, Gerard D. [6 ,7 ]
Crowder, Michael W. [1 ]
机构
[1] Miami Univ, Dept Chem & Biochem, 650 East High St, Oxford, OH 45056 USA
[2] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Chem Biol & Drug Discovery, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[4] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, 10701 East Blvd, Cleveland, OH USA
[5] Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, 107 W Dean Keeton, Austin, TX 78712 USA
[6] McMaster Univ, Michael G DeGroote Inst Infect Dis, 1280 Main St West, Hamilton, ON L8S 4L8, Canada
[7] McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St West, Hamilton, ON L8S 4L8, Canada
来源
ACS INFECTIOUS DISEASES | 2018年 / 4卷 / 02期
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
aspergillomarasmine A; metallo-beta-lactamase; NDM-1; VIM-2; IMP-7; antibiotic resistance; SPECTROSCOPIC CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; MOLECULAR-MECHANISMS; MULTIDRUG-RESISTANT; STRUCTURAL BASIS; ACTIVE-SITE; INHIBITORS; NMR; COORDINATION; COBALT(II);
D O I
10.1021/acsinfecdis.7b00106
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metallo-beta-lactamases (MBLs) are a growing threat to the continued efficacy of beta-lactam antibiotics. Recently, aspergillomarasmine A (AMA) was identified as an MBL inhibitor, but the mode of inhibition was not fully characterized. Equilibrium dialysis and metal analysis studies revealed that 2 equiv of AMA effectively removes 1 equiv of Zn(II) from MBLs NDM-1, VIM-2, and IMP-7 when the MBL is at micromolar concentrations. Conversely, H-1 NMR studies revealed that 2 equiv of AMA remove 2 equiv of Co(II) from Co(II)-substituted NDM-1, VIM-2, and IMP-7 when the MBL/AMA are at millimolar concentrations. Our findings reveal that AMA inhibits the MBLs by removal of the active site metal ions required for beta-lactam hydrolysis among the most clinically significant MBLs.
引用
收藏
页码:135 / 145
页数:11
相关论文
共 50 条
  • [1] α-Aminophosphonate inhibitors of metallo-β-lactamases NDM-1 and VIM-2
    Palica, Katarzyna
    Deufel, Fritz
    Skagseth, Susann
    Metzler, Gabriela Paula Di Santo
    Thoma, Johannes
    Rasmussen, Anna Andersson
    Valkonen, Arto
    Sunnerhagen, Per
    Leiros, Hanna-Kirsti S.
    Andersson, Hanna
    Erdelyi, Mate
    RSC MEDICINAL CHEMISTRY, 2023, 14 (11): : 2277 - 2300
  • [2] Probing the mechanisms of inhibition for various inhibitors of metallo-β-lactamases VIM-2 and NDM-1
    Thomas, Caitlyn A.
    Cheng, Zishuo
    Yang, Kundi
    Hellwarth, Elle
    Yurkiewicz, Cole J.
    Baxter, Faith M.
    Fullington, Sarah A.
    Klinsky, Spencer A.
    Otto, Jen L.
    Chen, Allie Y.
    Cohen, Seth M.
    Crowder, Michael W.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2020, 210
  • [3] Structural insights into the design of reversible fluorescent probes for metallo-?-lactamases NDM-1, VIM-2, and IMP-1
    Price, Sky
    Mehta, Radhika
    Tan, Dominique
    Hinojosa, Abigail
    Thomas, Pei W.
    Cummings, Tawanda
    Fast, Walter
    Que, Emily L.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2022, 233
  • [4] Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2
    Christopeit, Tony
    Leiros, Hanna-Kirsti S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (08) : 1973 - 1977
  • [5] Emergence of Carbapenem-Resistant Pseudomonas asiatica Producing NDM-1 and VIM-2 Metallo-β-Lactamases in Myanmar
    Tohya, Mari
    Tada, Tatsuya
    Watanabe, Shin
    Kuwahara-Arai, Kyoko
    Zin, Khwar Nyo
    Zaw, Ni Ni
    Aung, May Yee
    Mya, San
    Zan, Khin Nyein
    Kirikae, Teruo
    Tin, Htay Htay
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [6] First Organisms with Acquired Metallo-β-Lactamases (IMP-13, IMP-22, and VIM-2) Reported in Austria
    Duljasz, Wojciech
    Gniadkowski, Marek
    Sitter, Silvia
    Wojna, Alexandra
    Jebelean, Crista
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 2221 - 2222
  • [7] Comparative study of the inhibition of metallo-β-lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group
    Jin, WC
    Arakawa, Y
    Yasuzawa, H
    Taki, T
    Hashiguchi, R
    Mitsutani, K
    Shoga, A
    Yamaguchi, Y
    Kurosaki, H
    Shibata, N
    Ohta, M
    Goto, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (06) : 851 - 856
  • [8] Emergence of Pseudomonas aeruginosa strains producing metallo-β-lactamases of the IMP-15 and VIM-2 types in Mexico
    Quinones-Falconi, F.
    Galicia-Velasco, M.
    Marchiaro, P.
    Mussi, M. A.
    Ballerini, V.
    Vila, A. J.
    Viale, A. M.
    Bermejo-Morales, K.
    Limansky, A. S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) : 126 - 131
  • [9] Potential Inhibitors Against NDM-1 Type Metallo-β-Lactamases: An Overview
    Sharma, Smriti
    Sharma, Sumit
    Singh, Parvinder Pal
    Khan, Inshad Ali
    MICROBIAL DRUG RESISTANCE, 2020, 26 (12) : 1568 - 1588
  • [10] Emergence of sequence type 11 Klebsiella pneumoniae coproducing NDM-1 and VIM-1 metallo-β-lactamases in a Greek hospital
    Papagiannitsis, C. C.
    Malli, E.
    Florou, Z.
    Sarrou, S.
    Hrabak, J.
    Mantzarlis, K.
    Zakynthinos, E.
    Petinaki, E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 87 (03) : 295 - 297